Stay updated on ICT-107 Immunotherapy in GBM Clinical Trial
Sign up to get notified when there's something new on the ICT-107 Immunotherapy in GBM Clinical Trial page.

Latest updates to the ICT-107 Immunotherapy in GBM Clinical Trial page
- Check5 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check12 days agoChange DetectedThe footer’s site revision label was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe study record page displays a 403 Forbidden error, with navigation elements visible but no study details. This suggests an access or server issue rather than an update to the study content.SummaryDifference17%

- Check54 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a newer version of the page metadata. This update does not appear to change the study data or publicly listed details.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a minor platform/template update for the Study Details page without changes to study information.SummaryDifference0.0%

- Check91 days agoChange DetectedFooter revision updated from v3.6.3 to v3.6.4. This signals a minor frontend build update with no changes to the study details presented.SummaryDifference0.0%

Stay in the know with updates to ICT-107 Immunotherapy in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ICT-107 Immunotherapy in GBM Clinical Trial page.